Adjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of cancer

Administration of anti-4-1BB mAb has been found to be a potent adjuvant when combined with other therapeutic approaches, e.g. chemotherapy, cytokine therapies, anti-OX40 therapy, and peptide or DC vaccines. However, the adjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiao, Iuchi, Takekazu, Jure-Kunkel, Maria N., Chang, Alfred E.
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2007
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2096735/
https://www.ncbi.nlm.nih.gov/pubmed/18071585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2096735/
https://www.ncbi.nlm.nih.gov/pubmed/18071585

Ejemplares similares